ramucirumab (cyramza) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Fast Track FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

VA Big4

$86.2200 - $86.3338

VA FSS

$113.9800 - $113.9802

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ramucirumab 10 mg / 1 mL (1 mL SOLUTION) $86.2200 VA Big4
  • CYRAMZA (10)
    		•  Eli Lilly & Company
    ramucirumab 10 mg / 1 mL (1 mL SOLUTION) $86.3338 VA Big4
  • CYRAMZA (50)
    		•  Eli Lilly & Company
    ramucirumab 10 mg / 1 mL (1 mL SOLUTION) $113.9800 VA FSS
  • CYRAMZA (10)
    		•  Eli Lilly & Company
    ramucirumab 10 mg / 1 mL (1 mL SOLUTION) $113.9802 VA FSS
  • CYRAMZA (50)
    		•  Eli Lilly & Company

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue